{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-021371","form_type":"8-K","ticker":"ELUT","cik":"0001708527","company_name":"ELUTIA INC.","filed_at":"2025-03-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.528496+00:00","generated_at":"2026-05-25T06:46:08.468739+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Elutia Q4 2024: BioEnvelope sales +18% to $2.7M; EluPro pilot launch gains traction; net loss $9.1M","bullets":["Q4 BioEnvelope sales $2.7M (+18% YoY); overall net sales $5.5M (-7% YoY) due to SimpliDerm and cardiovascular declines.","EluPro accounted for over 30% of BioEnvelope sales in Q4; 67 approved accounts and ~100 actively ordering.","Q4 GAAP gross margin improved to 42.5% (from 36.2%); adjusted gross margin 58.1% (from 50.6%).","Full year 2024 net loss from continuing ops $54.1M vs $41.2M; adjusted EBITDA loss narrowed to $12.9M from $14.4M.","Year-end cash $13.2M; raised ~$15M gross proceeds in February 2025 registered direct offering."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-021371","json":"https://secwatch.observer/filing/0001104659-25-021371.json","markdown":"https://secwatch.observer/filing/0001104659-25-021371.md","text":"https://secwatch.observer/filing/0001104659-25-021371.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1708527/000110465925021371/0001104659-25-021371-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1708527/000110465925021371/tm258477d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T06:46:08.468739+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}